Expedient entry into 1,4-dihydroquinoxalines and quinoxalines via a novel variant of isocyanide-based MCR

Synlett

Volumn , Issue 5, 2008, Pages 645-648

  Krasavin, Mikhail ^a,b   Parchinsky, Vladislav ^a  

^a Chemical Diversity Research Institute   (Russian Federation)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Combinatorial chemistry; Dehydrogenations; Isocyanides; Multi component reactions; Quinoxalines

Indexed keywords

1,4 DIHYDROQUINOXALINE DERIVATIVE; BENZENE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYST; CHEMICAL REACTION; DEHYDROGENATION; OXIDATION; SYNTHESIS; X RAY ANALYSIS;

EID: 41349097979     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1032106     Document Type: Article

References (22)

1. Dömling, A. Chem. Rev. 2006, 106, 17.
2. Groebke, K.; Weber, L.; Mehlin, F. Synlett 1998, 661.
3. Bienaymé, H.; Bouzid, K. Angew. Chem. Int. Ed. 1998, 37, 2234.
4. Ilyn, A. P.; Loseva, M. V.; Vvedensky, V. Y.; Putsykina, E. B.; Tkachenko, S. E.; Kravchenko, D. V.; Khvat, A. V.; Krasavin, M. Y.; Ivachtchenko, A. V. J. Org. Chem. 2006, 71, 2811.
5. Mironov, M. A.; Ivantsova, M. N.; Mokrushin, V. S. Mol. Diversity 2003, 6, 193.
6. (a) Pirrung, M. C.; Das Sharma, K. J. Am. Chem. Soc. 2004, 126, 444.
7. (b) Kanizsai, I.; Gyónfalvi, S.; Szakonyi, Z.; Sillanpää, R.; Fülöp, F. Green Chem. 2007, 9, 357.
8. Parchinsky, V. Z.; Shuvalova, O.; Ushakova, O.; Kravchenko, D. V.; Krasavin, M. Tetrahedron Lett. 2006, 47, 947.
9. Parchinsky, V. Z.; Koleda, V. V.; Shuvalova, O.; Kravchenko, D. V.; Krasavin, M. Tetrahedron Lett. 2006, 47, 6891.
10. (a) One example of an aliphatic diamine participating in the intramolecular Ugi-type MCR has been reported in:Keung, W.; Bakir, F.; Patron, A. P.; Rogers, D.; Priest, C. D.; Darmohusodo, V. Tetrahedron Lett. 2004, 45, 733.
11. (b) An account of the use of ethylene diamines appeared in print when the present manuscript was in preparation: Kysil, V.; Tkachenko, S.; Khvat, A.; Williams, C.; Tsirulnikov, S.; Churakova, M.; Ivachtchenko, A. Tetrahedron Lett. 2007, 48, 6239.
12. 1)-substituted benzimidazole, presumably formed from the oxidative cyclization of the intermediate aldimine. This observation is in accordance with our previous results, see ref. 11b. The unwanted benzimidazole formation could be minimized by thorough exclusion of air from the reaction medium.
13. (b) Krasavin, M.; Kobak, V. V.; Bondarenko, T. Y.; Kravchenko, D. V. Heterocycles 2005, 65, 2189.
14. 3OS: 285.3703; found: 285.3703.
15. Crystallographic data (excluding structure factors) for the structure 5b have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 671798. Copies of the data can be obtained free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44 (1223)336033 or email: deposit@ccdc.cam.ac.uk].
16. Loriga, M.; Fiore, M.; Sanna, P.; Paglietti, G. Il Farmaco 1995, 50, 289.
17. Ding, S.; Gray, N. S.; Wu, X.; Ding, Q.; Schultz, P. G. J. Am. Chem. Soc. 2002, 124, 1594.
18. 4: 326.4044; found: 326.4047.
19. 3: 333.4806; found: 333.4803.
20. 4O: 378.5218; found: 378.5221.
21. Kajiki, T.; Moriya, H.; Hoshino, K.; Kuroi, T.; Kondo, S.; Nabeshima, T.; Yano, Y. J. Org. Chem. 1999, 61, 9679.
22. Linden, A. A.; Johansson, M.; Hermanns, N.; Bäckvall, J.-E. J. Org. Chem. 2006, 71, 3849.